85 related articles for article (PubMed ID: 24969546)
21. Brush cytology and the diagnosis of pancreaticobiliary malignancy during ERCP.
Lee JG
Gastrointest Endosc; 2006 Jan; 63(1):78-80. PubMed ID: 16377320
[No Abstract] [Full Text] [Related]
22. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
[TBL] [Abstract][Full Text] [Related]
23. Advances in the endoscopic management of patients with pancreatic and biliary malignancies.
Brugge WR
South Med J; 2006 Dec; 99(12):1358-66. PubMed ID: 17233192
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of diagnostic value of cytologic sampling by endoscopic ultrasonography-guided fine-needle aspiration and that by endoscopic retrograde pancreatography for the management of pancreatic mass without biliary stricture.
Wakatsuki T; Irisawa A; Bhutani MS; Hikichi T; Shibukawa G; Takagi T; Yamamoto G; Takahashi Y; Yamada Y; Watanabe K; Obara K; Suzuki T; Sato Y
J Gastroenterol Hepatol; 2005 Nov; 20(11):1707-11. PubMed ID: 16246190
[TBL] [Abstract][Full Text] [Related]
25. Value of endoscopic retrograde cholangiopancreatography-guided brushings in preoperative assessment of pancreaticobiliary strictures: what's new?
Athanassiadou P; Grapsa D
Acta Cytol; 2008; 52(1):24-34. PubMed ID: 18323272
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation.
Domagk D; Wessling J; Reimer P; Hertel L; Poremba C; Senninger N; Heinecke A; Domschke W; Menzel J
Am J Gastroenterol; 2004 Sep; 99(9):1684-9. PubMed ID: 15330902
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic retrograde wire-guided brush cytology for diagnosis of patients with malignant obstruction of the bile duct.
Foutch PG; Kerr DM; Harlan JR; Manne RK; Kummet TD; Sanowski RA
Am J Gastroenterol; 1990 Jul; 85(7):791-5. PubMed ID: 2164768
[TBL] [Abstract][Full Text] [Related]
28. Bile cytology. Diagnostic role in the management of biliary obstruction.
Nilsson B; Wee A; Yap I
Acta Cytol; 1995; 39(4):746-52. PubMed ID: 7631549
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of bile cytology in the diagnostic management of patients with biliary tract obstruction.
Cobb CJ; Floyd WN
Acta Cytol; 1985; 29(2):93-100. PubMed ID: 2984868
[TBL] [Abstract][Full Text] [Related]
30. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
Wakabayashi H; Akamoto S; Yachida S; Okano K; Izuishi K; Nishiyama Y; Maeta H
Eur J Surg Oncol; 2005 Dec; 31(10):1175-9. PubMed ID: 16019182
[TBL] [Abstract][Full Text] [Related]
31. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
[TBL] [Abstract][Full Text] [Related]
32. A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures.
Foutch PG; Kerr DM; Harlan JR; Kummet TD
Am J Gastroenterol; 1991 May; 86(5):577-80. PubMed ID: 2028947
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic retrograde brush cytology. A new technique.
Venu RP; Geenen JE; Kini M; Hogan WJ; Payne M; Johnson GK; Schmalz MJ
Gastroenterology; 1990 Nov; 99(5):1475-9. PubMed ID: 2210255
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
35. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
36. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
[TBL] [Abstract][Full Text] [Related]
37. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
Halme L; Arola J; Numminen K; Krogerus L; Mäkisalo H; Färkkilä M
Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
[TBL] [Abstract][Full Text] [Related]
39. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis.
Sturm PD; Rauws EA; Hruban RH; Caspers E; Ramsoekh TB; Huibregtse K; Noorduyn LA; Offerhaus GJ
Clin Cancer Res; 1999 Mar; 5(3):629-35. PubMed ID: 10100716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
